98%
921
2 minutes
20
Background: Percutaneous mitral valve repair (PMVR) is increasingly performed in patients with severe mitral regurgitation (MR). Post-procedural MR grading is challenging and an unsettled issue. We hypothesised that the direct planimetry of vena contracta area (VCA) by 3D-transoesophageal echocardiography allows quantifying post-procedural MR and implies further prognostic relevance missed by the usual ordinal scale (grade I-IV).
Methods: Based on a single-centre PMVR registry containing 102 patients, the association of VCA reduction and patients' functional capacity measured as six-minute walk distance (6 MW) was evaluated. 3D-colour-Doppler datasets were available before, during and 4 weeks after PMVR.
Results: Twenty nine patients (age 77.0 ± 5.8 years) with advanced heart failure (75.9% NYHA III/IV) and severe degenerative (34%) or functional (66%) MR were eligible. VCA was reduced in all patients by PMVR (0.99 ± 0.46 cm vs. 0.22 ± 0.15 cm, p < 0.0001). It remained stable after median time of 33 days (p = 0.999). 6 MW improved after the procedure (257.5 ± 82.5 m vs. 295.7 ± 96.3 m, p < 0.01). Patients with a decrease in VCA less than the median VCA reduction showed a more distinct improvement in 6 MW than patients with better technical result (p < 0.05). This paradoxical finding was driven by inferior results in very large functional MR.
Conclusions: VCA improves the evaluation of small residual MR. Its post-procedural values remain stable during a short-term follow-up and imply prognostic information for the patients' physical improvement. VCA might contribute to a more substantiated estimation of treatment success in the heterogeneous functional MR group.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759791 | PMC |
http://dx.doi.org/10.1186/s12947-017-0120-9 | DOI Listing |
Rev Esp Cardiol (Engl Ed)
September 2025
Unidad de Imagen Cardiaca, Departamento de Cardiología, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Electronic address:
Introduction And Objectives: Hepatic, portal, and intrarenal venous flows are impaired in significant tricuspid regurgitation (TR), but the impact of massive and torrential TR remains unclear. This study assessed these venous flow patterns across the 5-grade TR classification and their potential as grading markers.
Methods: Patients with TR were prospectively included from 3 centers.
Echocardiography
September 2025
Department of Cardiology, University of Health Sciences Trabzon Ahi Evren Thoracic and Cardiovascular Surgery Training and Research Hospital, Trabzon, Turkey.
Background: Currently, cardiac devices are widely used, and the effects of the electrodes of these devices on the tricuspid valve are being investigated. This study aimed to prospectively investigate, using two-dimensional echocardiography, the impact of electrode thickness on the development of tricuspid regurgitation (TR) and operator radiation exposure during the implantation of single-chamber implantable cardioverter-defibrillators (VVI-ICDs).
Methods: This prospective study included 61 patients treated at a single center between March 2023 and January 2024.
Quant Imaging Med Surg
August 2025
Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
Background: The tricuspid regurgitation (TR) syndrome, based on the extent of cardiac and extracardiac involvement, is a newly proposed staging method to evaluate the progression of TR. This study aimed to explore cardiac structural characteristics and the short-term prognosis after transcatheter tricuspid valve replacement (TTVR) in patients at different stages.
Methods: A post-hoc analysis of patients enrolled in the first-in-man and confirmatory study and an investigator-initiated trial of the LuX-Valve Plus system was conducted.
Eur Heart J Cardiovasc Imaging
July 2025
Department of Medicine and Clinical Science, Division of Cardiology, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, Ube, Yamaguchi 755-8505, Japan.
Aims: In advanced chronic aortic regurgitation (AR), left ventricular (LV) volume/pressure overload leads to LV hypertrophy and heart failure. Echocardiography often reveals gradual and continuous enlargement of the LV throughout diastole as AR adds to LV inflow. The severity, cardiac overload, and timing of therapeutic interventions in AR patients remain controversial.
View Article and Find Full Text PDFEur Heart J Imaging Methods Pract
January 2025
British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
Aims: To investigate the real-world, current clinical practice of the assessment and management of aortic regurgitation (AR).
Methods And Results: An electronic survey was distributed to cardiovascular imaging specialists by the European Society Association of Cardiovascular Imaging Scientific Initiatives Committee. Three hundred respondents from 66 countries completed the survey.